Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Shares Issued (2016 - 2025)

Fennec Pharmaceuticals' Shares Issued history spans 13 years, with the latest figure at $40.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 4926.85% year-over-year to $40.1 million, compared with a TTM value of $42.0 million through Dec 2025, up 3132.05%, and an annual FY2025 reading of $42.0 million, up 3132.05% over the prior year.
  • Shares Issued for Q4 2025 was $40.1 million at Fennec Pharmaceuticals, up from $1.8 million in the prior quarter.
  • The five-year high for Shares Issued was $40.1 million in Q4 2025, with the low at -$470000.0 in Q3 2024.
  • Average Shares Issued over 4 years is $2.9 million, with a median of $359000.0 recorded in 2024.
  • Year-over-year, Shares Issued crashed 318.6% in 2024 and then surged 4926.85% in 2025.
  • Tracing FENC's Shares Issued over 4 years: stood at $679000.0 in 2022, then rose by 10.01% to $747000.0 in 2023, then increased by 6.69% to $797000.0 in 2024, then surged by 4926.85% to $40.1 million in 2025.
  • Per Business Quant, the three most recent readings for FENC's Shares Issued are $40.1 million (Q4 2025), $1.8 million (Q3 2025), and -$185000.0 (Q2 2025).